Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018434
Filing Date
2019-06-27
Accepted
2019-06-27 17:17:26
Documents
1
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6255
  Complete submission text file 0000899243-19-018434.txt   7773
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
PureTech Health LLC (Reporting) CIK: 0001727395 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 19926308

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902
SIC: 2834 Pharmaceutical Preparations